Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Sex Health ; 19(5): 484-485, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-35786429

RESUMO

In response to the report by Abraham et al ., we present our observations of Trichomonas vaginalis (TV) detection in men tested at a public hospital laboratory in Melbourne, Australia, using a multiplex PCR. These studies provide valuable information about TV prevalence in urban communities.


Assuntos
Saúde Sexual , Tricomoníase , Vaginite por Trichomonas , Trichomonas vaginalis , Instituições de Assistência Ambulatorial , Feminino , Humanos , Masculino , Prevalência , Tricomoníase/diagnóstico , Tricomoníase/epidemiologia , Vaginite por Trichomonas/diagnóstico , Vaginite por Trichomonas/epidemiologia
3.
Infect Control Hosp Epidemiol ; 45(3): 343-350, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37887261

RESUMO

OBJECTIVE: To estimate cost savings after implementation of customized electronic duplicate order alerts. DESIGN: Alerts were implemented for microbiology tests at the largest public hospital in Victoria, Australia. These alerts were designed to pop up at the point of test ordering to inform the clinician that the test had previously been ordered and to suggest appropriate reordering time frames and indications. RESULTS: In a 6-month audit of urine culture (our most commonly ordered test) after alert implementation, 2,904 duplicate requesters proceeded with the request and 2,549 tests were cancelled, for a 47% reduction in test ordering. For fecal polymerase chain reaction (PCR), our second most common test, there was a 54% reduction in test ordering. For our most commonly ordered expensive test, hepatitis C PCR, there was a 42% reduction in test ordering: 25 tests were cancelled.Cancelled tests resulted in estimated savings of AU$52,382 (US$33,960) for urine culture, AU$34,914 (US$22,442) for fecal PCR, AU$4,506 (US$2,896) for hepatitis C PCR. For cancelled hepatitis B PCR and Epstein-Barr virus (EBV) and cytomegalovirus (CMV) serology, the cost savings was AU$8,472 (US$5445). The estimated financial cost saving in direct hospital costs for these 6 assays was AU$100,274 (US$67,925) over the 6-month period. Environmental waste cost saving by weight was estimated to be 280 kg. Greenhouse gas footprint, measured in carbon dioxide equivalent emissions for cancelled EBV and CMV serology tests, resulted in a saving of at least 17,711 g, equivalent to driving 115 km in a standard car. CONCLUSION: Customized alerts issued at the time of test ordering can have enormous impacts on reducing cost, waste, and unnecessary testing.


Assuntos
Infecções por Citomegalovirus , Infecções por Vírus Epstein-Barr , Hepatite C , Humanos , Redução de Custos , Herpesvirus Humano 4 , Hospitais Públicos
4.
J Correct Health Care ; 29(4): 293-298, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-37220011

RESUMO

The goal of the intensive outpatient program was to provide services to individuals who presented with co-occurring mental health and substance abuse disorders. These services were provided to incarcerated individuals during their involvement with a large Midwestern jail facility in efforts to reduce recidivism. Behavior change is a difficult process for any population, but for those with co-occurring mental health and substance abuse disorders, it is particularly challenging. With psychotherapeutic interventions, there may be therapeutic benefits that are occurring through outcomes such as increased insight into one's problems, attitudinal shifts, or improved coping that cannot be captured by tracking recidivism.


Assuntos
Transtornos Mentais , Prisioneiros , Transtornos Relacionados ao Uso de Substâncias , Humanos , Prisioneiros/psicologia , Prisões Locais , Pacientes Ambulatoriais , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/terapia , Saúde Mental , Transtornos Mentais/epidemiologia , Transtornos Mentais/terapia
5.
Med J Aust ; 195(9): 530-3, 2011 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-22060088

RESUMO

OBJECTIVE: To assess the frequency of, and risk factors for, colonisation with vancomycin-resistant enterococci (VRE), Clostridium difficile and extended-spectrum ß-lactamase (ESBL)-producing organisms in residential aged care facilities (RACFs). DESIGN, SETTING AND PARTICIPANTS: We conducted a point prevalence survey in October-November 2010 in three RACFs associated with our health service. A single faecal sample was collected from each participating resident and screened for the presence of VRE, C. difficile and ESBL-producing organisms. Presence of risk factors for antibiotic-resistant organisms was identified using a questionnaire. MAIN OUTCOME MEASURES: Prevalence of colonisation with VRE, C. difficile and ESBL-producing organisms; molecular typing of ESBL-producing organisms; prevalence of risk factors including presence of a urinary catheter, recent inpatient stay in an acute care setting and recent antibiotic consumption. RESULTS: Of 164 residents in the three facilities, 119 (73%) were screened. Mean age of screened residents was 79.2 years, and 61% were women; 74% had resided in the RACF for > 12 months, 21% had been given antibiotics within the past month and 12% had been in an acute care centre within the past 3 months. Overall rates of VRE (2%) and C. difficile (1%) colonisation were low, but ESBL-producing Escherichia coli was detected in 14 residents (12%) overall, with half of these residing in one wing of an RACF (27% of wing residents tested). Ten of the 14 ESBL-producing isolates had identical molecular typing patterns and belonged to genotye CTX-M-9. Eight of 13 residents had persistent colonisation on repeat testing 3 months later. CONCLUSION: We found a high prevalence of multiresistant ESBL-producing E. coli in RACF residents. A clonal relatedness of isolates suggests possible transmission within the facility. RACFs should have programs emphasising processes that will limit spread of these organisms, namely good hand hygiene compliance, enhanced environmental cleaning and dedicated antimicrobial stewardship programs.


Assuntos
Portador Sadio/epidemiologia , Clostridioides difficile , Infecções por Clostridium/epidemiologia , Farmacorresistência Bacteriana , Enterococcus , Infecções por Escherichia coli/epidemiologia , Infecções por Bactérias Gram-Positivas/epidemiologia , Instituição de Longa Permanência para Idosos , Casas de Saúde , Adulto , Idoso , Idoso de 80 Anos ou mais , Clostridioides difficile/efeitos dos fármacos , Infecções por Clostridium/tratamento farmacológico , Farmacorresistência Bacteriana Múltipla , Enterococcus/efeitos dos fármacos , Infecções por Escherichia coli/tratamento farmacológico , Feminino , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Resistência a Vancomicina , Vitória/epidemiologia , Resistência beta-Lactâmica
6.
Pathology ; 53(2): 257-263, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33036769

RESUMO

Trichomonas vaginalis (TV) infection is the leading cause of non-viral sexually transmitted infection (STI) globally and is endemic in rural and remote Australia. However, current accurate prevalence data for TV in urban Australia are scarce as TV is not a notifiable infection outside of the Northern Territory (NT). This study evaluated Australian guidelines for TV testing and determined TV prevalence among patients at a large urban public hospital in Melbourne, Australia. A retrospective analysis of genitourinary samples screened for STIs by multiplex polymerase chain reaction (MPCR) between May 2017 and April 2019 was performed. A total of 7155 results (5064 females) were included in the analysis. A prevalence for TV of 1.7% (n=123) was found, which was higher than Neisseria gonorrhoeae (1.4%, n=103) but less than Chlamydia trachomatis (5%, n=358). The highest rate of TV (3%) was found in females aged 30-44 years (n = 48). Routine MPCR improved TV detection almost six-fold compared with clinician request based testing. Current targeted testing guidelines for TV were inadequate for case finding in an urban setting, and clinical request among symptomatic patients was rare. MPCR testing provides a comprehensive testing strategy for curable STI, and removes the need for clinical suspicion of TV. Implementation of MPCR for STI screening can improve TV detection in populations not normally suspected to be at risk and therefore potentially reduce disease transmission or complications associated with undiagnosed infection.


Assuntos
Tricomoníase , Trichomonas vaginalis/isolamento & purificação , Adolescente , Adulto , Idoso , Austrália/epidemiologia , Criança , Pré-Escolar , Testes Diagnósticos de Rotina , Feminino , Genes de Protozoários , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase Multiplex , Northern Territory/epidemiologia , Prevalência , Estudos Retrospectivos , População Rural , Infecções Sexualmente Transmissíveis/diagnóstico , Infecções Sexualmente Transmissíveis/epidemiologia , Tricomoníase/diagnóstico , Tricomoníase/epidemiologia , Tricomoníase/transmissão , Trichomonas vaginalis/genética
7.
Int J STD AIDS ; 26(13): 974-81, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25577597

RESUMO

We report a case of disseminated Mycobacterium haemophilum osteomyelitis in a patient with advanced HIV infection, who later developed recurrent immune reconstitution inflammatory syndrome after commencement of antiretroviral therapy. We review previous reports of M. haemophilum bone and joint infection associated with HIV infection and describe the management of M. haemophilum-associated immune reconstitution inflammatory syndrome, including the role of surgery as an adjunctive treatment modality and the potential drug interactions between antiretroviral and antimycobacterial agents.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções por HIV/complicações , Síndrome Inflamatória da Reconstituição Imune/complicações , Infecções por Mycobacterium/diagnóstico , Mycobacterium haemophilum/isolamento & purificação , Osteomielite/microbiologia , Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Infecções Oportunistas Relacionadas com a AIDS/microbiologia , Adulto , Articulação do Tornozelo , Antibacterianos/uso terapêutico , Fármacos Anti-HIV/uso terapêutico , Desbridamento , Infecções por HIV/tratamento farmacológico , Humanos , Síndrome Inflamatória da Reconstituição Imune/microbiologia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium/tratamento farmacológico , Infecções por Mycobacterium/microbiologia , Mycobacterium haemophilum/genética , Osteomielite/diagnóstico , Osteomielite/terapia , Reação em Cadeia da Polimerase , Tenossinovite/microbiologia , Tenossinovite/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA